Akdeniz Hall (Hall 2)
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
Following the opening remarks, the session will address regulatory perspectives on GMP Guide Annex 22 and artificial intelligence applications; subsequently, the journey of biotechnological drugs from R&D to production will be comprehensively explored, with expert insights on biosimilars, clinical exemptions, and domestic manufacturing strategies.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Ümit KERVAN, TÜSEB President
>Hüseyin ÇELİK, TİTCK President
Regulatory Affairs and Legal Requirements in Pharmaceuticals
From Big Data to Early Diagnosis: AI-Assisted Journey in Rare Diseases
> Dr. Hasan Berk BARIŞCIL,SANOFI Rare Diseases Medical Manager
The Future of National and International Pharmaceutical Markets: Potential Challenges and Solution Scenarios
Moderator:
>Umit DERELI, Secretary General of AIFD
>Savas MALKOC, Secretary General of IEIS
>Sami TURKOGLU, MD, Secretary General of TISD
The Clinical Journey Shaping the Future: Technology, People, Vision
> Dilek ÖZCAN EKŞİ, Senior Manager of Developement Operations, AMGEN Türkiye
Current Applications of Personalized Medicine via Genomic Approaches
> Prof. Dr. Fatma Duygu ÖZEL DEMİRALP, President of Biotechnology Institute of Türkiye
> Dr. Öğr. Üyesi Rizvan İMAMOĞLU, Researcher, Biotechnology Institute of Türkiye
Turkey’s Position and Future in the Global Biopharmaceutical Sector
> Dr. Hasan Ersin ZEYTİN, CEO of Yerlika
Novel Biotechnological Molecules and Production Technologies in National and International Markets
Moderatör: Prof.Dr. Ali Demir SEZER
>Dr. Bilgen DÖLEK UÇAROL, Market Access and Health Policy Lead, AMGEN Turkiye
>Dr. Hasan Ersin ZEYTİN, CEO of YERLIKA
>Levent GÜNDEĞER, EEMEA Regional Director, CYTIVA Türkiye
>Ecz. Onur PINARBAŞLI, R&D Director of ILKO
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Orhan AYDIN, TÜBİTAK President
>Doç. Dr. Eren USUL, General Manager of SGK General Health Insurance
R&D Ecosystem and Supports for Biotechnological Drugs in TÜBİTAK
> Işık AŞAR, Acting Coordinator of BIYOTEG - TÜBİTAK TEYDEB
The Importance of Innovation in Industry-Academia Collaboration
> Prof. Dr. Ersoy KOCABIÇAK, Rector of Istanbul Atlas University
Localization in Pharmaceuticals Indutry: Human Resources, Infrastructure, and Ecosystem Model
Moderatör: M. Adil KAYA, Atabay İlaç ve Kimya Sanayi
> Berk ÖZDEMİR, CEO of OMEGA Research
> Erdinç YAŞRİN, TİYSAT President
Biopharmaceutical Development Processes
Moderator: Prof. Dr. Ali Osman KILIÇ, İzmir Biomedicine and Genome Center
> Dr. Sibel KALYONCU - Dr. Ayça Z. KUYUCU
From Discovery to Candidate Product: The Biopharmaceutical Development Journey
> Specialist Pharmacist Ayşegül DEMİRTAŞ
Preclinical Pharmacology and Toxicology Studies for Biopharmaceutical Candidates
Clinical Trials and Artificial Intelligence in Biopharmaceuticals
Moderator: Prof. Dr. Yağız ÜRESİN, Istanbul University
> Umut MÜREN, Clinical Research Unit Director, Sanofi Turkey and Middle East
> Assoc. Prof. Dr. Mustafa ÜNAL, Head of Clinical Research Department, TÜSEB
> Birkan AVER, Medical Area Manager, Primary Care, Pfizer Turkey
> Gülay Gökçe ÖZEL, Director of Clinical Research Turkey, Thermo Fisher Scientific
Healthcare Financing and Sustainability in the Health Sector
> Pharm. Spec. Ayşegül GÜNBEY ÖZTEK, Deputy Director General of General Health Insurance, SGK
Open to invited participants only.
Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
Table 1: Localization in Pharmaceuticals, API and Biotechnological Production Strategies
Table 2: Clinical Research, Artificial Intelligence and Innovative Data Models
Table 3: Licensing, Regulation and International Market Access
Table 4: Financing of Health Technologies, SSI Reimbursement and Sustainability
Searching for the Future Together in the Pharmaceutical Industry
> Hüseyin ÇELİK, TİTCK President
